The association between population-based treatment guidelines and adjuvant therapy for node-negative breast cancer
1997

Impact of Treatment Guidelines on Breast Cancer Therapy

Sample size: 1880 publication Evidence: high

Author Information

Author(s): C Sawka, I Olivotto, A Coldman, V GoeJ, E Holowaty, TG Hislop

Primary Institution: University of Toronto

Hypothesis

Care would be more consistent in British Columbia than in Ontario, and this difference would be associated with the presence of province-wide treatment guidelines in British Columbia.

Conclusion

Population-based treatment guidelines can promote consistent patterns of adjuvant therapy for women with node-negative breast cancer.

Supporting Evidence

  • Consistency of care was greater in British Columbia than in Ontario by all diagnostic grouping systems.
  • Patterns of pathology reporting in British Columbia were consistent with the treatment guidelines.
  • Adjuvant systemic therapy was used more frequently in Ontario than in British Columbia for certain cases.

Takeaway

This study looked at how treatment guidelines affect breast cancer care in two provinces. It found that following guidelines helps doctors give more consistent treatments.

Methodology

A retrospective population-based cohort study comparing treatment received by women with node-negative breast cancer in British Columbia and Ontario.

Potential Biases

Differences in the organization of medical care systems between provinces may have influenced results.

Limitations

Possible undetected differences in data quality, missing data on treatment use in Ontario, and lack of detailed information on co-morbidities.

Participant Demographics

942 cases in British Columbia and 938 cases in Ontario, with a notable age difference favoring older patients in British Columbia.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication